MedTrace Logo

Optical Head-Mounted Display Technology for Low Vision Rehabilitation

NCT02983305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-10-09

Study results available
· View outcomes & findings →

Summary

The goal of this study is to examine the ability of optical head-mounted display technology to enlarge the visual field of patients with severe visual field loss due to retinal dystrophy and to improve mobility and patient-reported outcomes.

Conditions

  • Retinal Dystrophies
  • Healthy

Interventions

DEVICE

Head-Mounted Display

Head-mounted displays (HMD) are a class of technology that are worn on the user's head and project an image either in front of or into the eye.

Sponsors & Collaborators

Principal Investigators

  • Joshua R Ehrlich, MD, MPH · University of Michigan

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2018-11-21
Completion
2018-11-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02983305 on ClinicalTrials.gov